From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease

Author： S. Brocardo Patricia M. Gil-Mohapel Joana

ISSN： 2211-5579

Source： Current Psychopharmacology, Vol.2, Iss.2, 2013-05, pp. : 113-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Neuroprotection in Huntington;s Disease

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 143-147

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic strategies in Huntington’s disease

By Alberch Jordi Canals Josep M Pérez-Navarro Esther

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

A review of the treatment options for Huntington’s disease

By Bonelli Raphael M Hofmann Peter

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 767-776

Informa Healthcare

Access to resources Recommend Favorite

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon Ferrante Robert J

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite